Skip to content

Research at St Andrews

COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper

Research output: Contribution to journalReview article

Standard

COVID-19 and substance use disorders : Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper. / Farhoudian, Ali; Baldacchino, Alexander Mario; Clark, Nicolas; Gerra, Gilberto; Ekhtiari, Hamed; Dom, Geert; Mokri, Azarakhsh; Sadeghi, Mandana; Nematollahi, Pardris; Demasi, Maryanne; Schütz, Christian G.; Hashemian, Seyed Mohammadreza; Tabarsi, Payam; Galea-Singer, Susanna; Carrà, Giuseppe; Clausen, Thomas; Kouimtsidis, Christos; Tolomeo, Serenella; Radfar, Seyed Ramin; Razaghi, Emran Mohammed.

In: Basic and Clinical Neuroscience, Vol. Special Issue on COVID-19, 12.04.2020, p. 129-146.

Research output: Contribution to journalReview article

Harvard

Farhoudian, A, Baldacchino, AM, Clark, N, Gerra, G, Ekhtiari, H, Dom, G, Mokri, A, Sadeghi, M, Nematollahi, P, Demasi, M, Schütz, CG, Hashemian, SM, Tabarsi, P, Galea-Singer, S, Carrà, G, Clausen, T, Kouimtsidis, C, Tolomeo, S, Radfar, SR & Razaghi, EM 2020, 'COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper', Basic and Clinical Neuroscience, vol. Special Issue on COVID-19, pp. 129-146. https://doi.org/10.32598/bcn.11.covid19.1

APA

Farhoudian, A., Baldacchino, A. M., Clark, N., Gerra, G., Ekhtiari, H., Dom, G., Mokri, A., Sadeghi, M., Nematollahi, P., Demasi, M., Schütz, C. G., Hashemian, S. M., Tabarsi, P., Galea-Singer, S., Carrà, G., Clausen, T., Kouimtsidis, C., Tolomeo, S., Radfar, S. R., & Razaghi, E. M. (2020). COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper. Basic and Clinical Neuroscience, Special Issue on COVID-19, 129-146. https://doi.org/10.32598/bcn.11.covid19.1

Vancouver

Farhoudian A, Baldacchino AM, Clark N, Gerra G, Ekhtiari H, Dom G et al. COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper. Basic and Clinical Neuroscience. 2020 Apr 12;Special Issue on COVID-19:129-146. https://doi.org/10.32598/bcn.11.covid19.1

Author

Farhoudian, Ali ; Baldacchino, Alexander Mario ; Clark, Nicolas ; Gerra, Gilberto ; Ekhtiari, Hamed ; Dom, Geert ; Mokri, Azarakhsh ; Sadeghi, Mandana ; Nematollahi, Pardris ; Demasi, Maryanne ; Schütz, Christian G. ; Hashemian, Seyed Mohammadreza ; Tabarsi, Payam ; Galea-Singer, Susanna ; Carrà, Giuseppe ; Clausen, Thomas ; Kouimtsidis, Christos ; Tolomeo, Serenella ; Radfar, Seyed Ramin ; Razaghi, Emran Mohammed. / COVID-19 and substance use disorders : Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper. In: Basic and Clinical Neuroscience. 2020 ; Vol. Special Issue on COVID-19. pp. 129-146.

Bibtex - Download

@article{7a88aae1b1dc4660ab29c833c99786ce,
title = "COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper",
abstract = "Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).",
keywords = "Coronavirus, Coronavirus disease 2019 (COVID-19), Pandemic, Public health, Subtance use disorder, Addiction medicine, Harm reduction, Policy, Methadone, Opioid substitution therapy",
author = "Ali Farhoudian and Baldacchino, {Alexander Mario} and Nicolas Clark and Gilberto Gerra and Hamed Ekhtiari and Geert Dom and Azarakhsh Mokri and Mandana Sadeghi and Pardris Nematollahi and Maryanne Demasi and Sch{\"u}tz, {Christian G.} and Hashemian, {Seyed Mohammadreza} and Payam Tabarsi and Susanna Galea-Singer and Giuseppe Carr{\`a} and Thomas Clausen and Christos Kouimtsidis and Serenella Tolomeo and Radfar, {Seyed Ramin} and Razaghi, {Emran Mohammed}",
year = "2020",
month = apr,
day = "12",
doi = "10.32598/bcn.11.covid19.1",
language = "English",
volume = "Special Issue on COVID-19",
pages = "129--146",
journal = "Basic and Clinical Neuroscience",
issn = "2008-126X",
publisher = "Iran University of Medical Sciences",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - COVID-19 and substance use disorders

T2 - Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper

AU - Farhoudian, Ali

AU - Baldacchino, Alexander Mario

AU - Clark, Nicolas

AU - Gerra, Gilberto

AU - Ekhtiari, Hamed

AU - Dom, Geert

AU - Mokri, Azarakhsh

AU - Sadeghi, Mandana

AU - Nematollahi, Pardris

AU - Demasi, Maryanne

AU - Schütz, Christian G.

AU - Hashemian, Seyed Mohammadreza

AU - Tabarsi, Payam

AU - Galea-Singer, Susanna

AU - Carrà, Giuseppe

AU - Clausen, Thomas

AU - Kouimtsidis, Christos

AU - Tolomeo, Serenella

AU - Radfar, Seyed Ramin

AU - Razaghi, Emran Mohammed

PY - 2020/4/12

Y1 - 2020/4/12

N2 - Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

AB - Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

KW - Coronavirus

KW - Coronavirus disease 2019 (COVID-19)

KW - Pandemic

KW - Public health

KW - Subtance use disorder

KW - Addiction medicine

KW - Harm reduction

KW - Policy

KW - Methadone

KW - Opioid substitution therapy

U2 - 10.32598/bcn.11.covid19.1

DO - 10.32598/bcn.11.covid19.1

M3 - Review article

VL - Special Issue on COVID-19

SP - 129

EP - 146

JO - Basic and Clinical Neuroscience

JF - Basic and Clinical Neuroscience

SN - 2008-126X

ER -

Related by author

  1. Psychological basis of obesity

    Tsegaye, A., Kökönyei, G., Baldacchino, A. M., Urbán, R., Demetrovics, Z. & Logemann, H. N. A., 8 Jun 2020, Obesity and Obstetrics. Mahmood, T., Arulkumaran, S. & Chervenak, F. (eds.). 2nd ed. Netherlands: Elsevier, p. 37-44 8 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  2. Psychological impact of the acute COVID-19 period on patients with substance use disorders (SUD): we are all in it together

    DeJong, C. A. J., DeJong Verhagen, J. G., Pols, R., Verbrugge, C. A. G. & Baldacchino, A. M., 6 Jun 2020, In : Basic and Clinical Neuroscience. 11, 3.Covid 19, p. 163-172

    Research output: Contribution to journalArticle

  3. Pharmacogenetics of opioid addiction: are they relevant to young people?

    Davey, F. & Baldacchino, A. M., 7 Jan 2020, Substance Misuse and Young People: Critical Issues. Crome, I. & Williams, R. (eds.). 2 Park Square, Milton Park, Abingdon, Oxon OX14 4RN: Routledge, p. 118-126

    Research output: Chapter in Book/Report/Conference proceedingChapter

  4. Neurocognitive consequences of chronic cannabis use: a systematic review and meta-analysis

    Figureiredo, P., Tolomeo, S., Steele, D. & Baldacchino, A. M., Jan 2020, In : Neuroscience and Biobehavioral Reviews. 108, p. 358-369

    Research output: Contribution to journalArticle

Related by journal

  1. Psychological impact of the acute COVID-19 period on patients with substance use disorders (SUD): we are all in it together

    DeJong, C. A. J., DeJong Verhagen, J. G., Pols, R., Verbrugge, C. A. G. & Baldacchino, A. M., 6 Jun 2020, In : Basic and Clinical Neuroscience. 11, 3.Covid 19, p. 163-172

    Research output: Contribution to journalArticle

ID: 267395171

Top